KEEPING YOU UP TO DATEClearstate Healthcare InsightsClearstate Insights is your single source to all our latest healthcare intelligence. From recently published reports offering thought-provoking analysis, to information about new products and services, we will ensure you are always kept informed. Sign up to Clearstate’s newsletter
Reimbursement of robotic surgery expected to increase in Asia Reimbursement and the affordability of digital health… Orthopaedic & Spine Surgery | Robotic surgery | Surgical device and IVD | Asia | Orthopaedic & Spine Surgery | Robotic surgery | Surgical Gateway
How government policies will drive South Korea’s robotic surgery market Digital technology is emerging as a long-term driver of… Orthopaedic & Spine Surgery | Robotic surgery | Surgical device and IVD | Asia | Orthopaedic & Spine Surgery | Robotic surgery | Surgical Gateway
How Indonesia’s healthcare transformation will impact its IVD market Indonesia’s in-vitro diagnostics (IVD) market will recover… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Asia | Centralised Diagnostics (CEDx) | IVD Gateway | Molecular Diagnostics (MDx) | Point-of-care testing (POCT)
How inflation will impact Brazil’s IVD market Brazil’s in-vitro diagnostics (IVD) market will recover in… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Uncategorised | Americas
APAC IVD market to shrink by 2026 as demand for covid-19 testing cools further The Asia-Pacific (APAC) in-vitro diagnostics (IVD) market… In-vitro diagnostics | Asia | IVD Gateway
LATAM IVD market: fastest-growing emerging market region from 2021-2026 The Latin America (LATAM) in-vitro diagnostics (IVD) market… In-vitro diagnostics | Americas | IVD Gateway
Asia-Pacific infectious disease diagnostics market trends In Asia-Pacific (APAC), many countries continue to build up… In-vitro diagnostics | Infectious Diseases Testing Monitor | Uncategorised | Asia | Infectious Diseases Testing Monitor | IVD Gateway
Elective surgery volume expected to make full recovery in 2023-24 Clearstate estimates that it will take until early 2024 to… Cardiovascular surgery | Orthopaedic & Spine Surgery | Surgical device and IVD | Asia | Cardiovascular Surgery | Orthopaedic & Spine Surgery | Surgical Gateway | Surgical Procedure Volume Segmentation
Medtech 2022/2023: seeking sustainable growth Global healthcare spending growth in 2022 has slowed despite… In-vitro diagnostics | Surgical device and IVD | Global | IVD Gateway | Surgical Gateway
Highlights from the 2022 APAC surgical device market briefing Growth opportunities for surgical device companies are… General surgery | Surgical device and IVD | Asia | General Surgery | Surgical Gateway
How Vision 2030 is driving growth in Saudi Arabia’s IVD market The incidence of cardiovascular diseases (CVD) in… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Middle East & Africa | Centralised Diagnostics (CEDx) | IVD Gateway | Molecular Diagnostics (MDx)
Middle East IVD market to recover to pre-pandemic growth rates from 2024 The Middle East IVD market has mostly recovered to… Centralised Diagnostics (CEDx) | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Middle East & Africa | Centralised Diagnostics (CEDx) | IVD Gateway | Molecular Diagnostics (MDx) | Point-of-care testing (POCT)
Sign up to our free newsletterThe latest trends and insights into the IVD and Surgical sectors, from our specialists and analysts, delivered directly to your inbox. Sign up to Clearstate’s newsletter today. Sign up now